Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > AusBiotech supports 'Raising the Bar'

Abstract:
AusBiotech welcomes a legislative Bill that has been introduced into the
Australian Parliament today - The Intellectual Property Laws Amendment
(Raising the Bar) Bill 2011.

AusBiotech supports 'Raising the Bar'

Australia | Posted on June 21st, 2011

AusBiotech confirms its support in general for this package of
intellectual property reform developed by IP Australia and contained in
the 'Raising the Bar' Bill. Specifically, AusBiotech is in favour of a
broad research use exemption from patent infringement becoming enshrined
in Australia's patent law so this country's researchers and industry may
be confident as they strive to innovate.

In its recent submission to the Senate Inquiry into the Patent Amendment
(Human Genes & Biological Materials) Bill 2010, AusBiotech stated its
belief that the thresholds for patentability should be properly set and
rigorously applied across all forms of invention, ie: in a
technology-neutral manner. AusBiotech has publicly and strongly opposed
the Patent Amendment (Human Genes & Biological Materials) Bill 2010, as
it completely fails to address any of the community's valid concerns and
threatens scientific research and development on biological materials.

AusBiotech is instead in favour of the Government's 'Raising the Bar'
Bill which, when taken together with the erudite recommendations from
the Australian Law Reform Commission 1999 report, the Senate Inquiry
into Gene Patents (2010) and the Advisory Council on Intellectual
Property 2010 review will deliver the solutions to address the issues
identified by clinicians, researchers, industry and the community.

AusBiotech strongly encourages the Australian Parliament to support the
Bill so that the many consequential benefits of the law reform can be
effected.

Dr Anna Lavelle, CEO of AusBiotech said: "Two years of consultation and
deliberation that has resulted in the "Raising the Bar' Bill, will
guarantee a strengthening of Australia's IP management system."

####

About AusBiotech
AusBiotech is Australia's voice on biotechnology, and represents more
than 3,000 members, encompassing medicines, medical diagnostics and
devices, agriculture, alternative fuels and climate change.

For more information, please click here

Contacts:
Lorraine Chiroiu
AusBiotech
Communications Manager
03 9828 1414 / 0429 801118

Copyright © AusBiotech

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Metal oxide sandwiches: New option to manipulate properties of interfaces February 8th, 2016

Canadian physicists discover new properties of superconductivity February 8th, 2016

Leading bugs to the death chamber: A kinder face of cholesterol February 8th, 2016

From allergens to anodes: Pollen derived battery electrodes February 8th, 2016

Govt.-Legislation/Regulation/Funding/Policy

Chiral magnetic effect generates quantum current: Separating left- and right-handed particles in a semi-metallic material produces anomalously high conductivity February 8th, 2016

Canadian physicists discover new properties of superconductivity February 8th, 2016

Leading bugs to the death chamber: A kinder face of cholesterol February 8th, 2016

From allergens to anodes: Pollen derived battery electrodes February 8th, 2016

Announcements

Scientists create laser-activated superconductor February 8th, 2016

Canadian physicists discover new properties of superconductivity February 8th, 2016

Leading bugs to the death chamber: A kinder face of cholesterol February 8th, 2016

From allergens to anodes: Pollen derived battery electrodes February 8th, 2016

Patents/IP/Tech Transfer/Licensing

Joint Efforts by Iranian, Malaysian Scientists Produce Antibacterial Coatings for Isolated Areas February 4th, 2016

Silicon-based metamaterials could bring photonic circuits February 1st, 2016

Therapeutic Solutions International Licenses Dexosome Clinical Stage Cancer Immunotherapy Product From Gustave Roussy European Cancer Centre: FDA Cleared Immuno-Oncology Technology to Resume Clinical Development for Solid Tumor Patients January 27th, 2016

Light-activated nanoparticles prove effective against antibiotic-resistant 'superbugs' January 19th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic